810143C

14:0 NBD PE

Avanti Research^™ - A Croda Brand 810143C

• 동의어(들): 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
• 실험식(Hill 표기법): C₃₉H₇₀N₅O₁₁P
• CAS Number: 474942-82-0
• Molecular Weight: 815.97
• UNSPSC 코드: 12352211
• NACRES: NA.25

속성

• 분석: >99% (TLC)
• 형태: liquid
• 포장: pkg of 1 × 1 mL (810143C-1mg); pkg of 5 × 1 mL (810143C-5mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 810143C
• 농도: 1 mg/mL (810143C-1mg); 1 mg/mL (810143C-5mg)
• 배송 상태: dry ice
• 저장 온도: −20°C

설명

애플리케이션

14:0 NBD PE is suitable for the preparation of phospholipid vesicles for lipid mixing assay. It is also suitable to use as fluorescent phospholipid derivative to study the effect of its exchange between β-lactoglobulin (β-LG) and phosphatidylcholine (POPC) bilayers.

생화학적/생리학적 작용

NBD PE (1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)) can be used liposome preparation. In which, it might serve as a measure of steady-state fluorescence anisotropy. This might be useful to analyse the mitochondrial membrane structure.

포장

5 mL Amber Glass Screw Cap Vial (810143C-1mg)

5 mL Amber Glass Screw Cap Vial (810143C-5mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 예방조치 성명서: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system, Liver,Kidney
• WGK: WGK 3